PEAK6 Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1496 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1564 |
|
|
2024
Q1 | – | Sell |
-3,277
| Closed | -$432K | – | 1643 |
|
|
2023
Q4 | $432K | Buy |
3,277
+1,305
| +66% | +$172K | ﹤0.01% | 543 |
|
|
2023
Q3 | $222K | Buy |
+1,972
| New | +$222K | ﹤0.01% | 674 |
|
|
2022
Q1 | – | Sell |
-5,070
| Closed | -$432K | – | 2274 |
|
|
2021
Q4 | $432K | Sell |
5,070
-2,791
| -36% | -$238K | ﹤0.01% | 890 |
|
|
2021
Q3 | $754K | Buy |
+7,861
| New | +$754K | ﹤0.01% | 767 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2265 |
|
|
2021
Q1 | – | Sell |
-8,319
| Closed | -$797K | – | 2055 |
|
|
2020
Q4 | $797K | Sell |
8,319
-3,711
| -31% | -$356K | ﹤0.01% | 743 |
|
|
2020
Q3 | $1.16M | Buy |
12,030
+2,316
| +24% | +$223K | ﹤0.01% | 498 |
|
|
2020
Q2 | $1.19M | Sell |
9,714
-6,337
| -39% | -$773K | ﹤0.01% | 403 |
|
|
2020
Q1 | $1.39M | Buy |
16,051
+13,465
| +521% | +$1.17M | 0.01% | 291 |
|
|
2019
Q4 | $278K | Sell |
2,586
-20,787
| -89% | -$2.23M | ﹤0.01% | 654 |
|
|
2019
Q3 | $2.11M | Sell |
23,373
-5,109
| -18% | -$460K | 0.01% | 267 |
|
|
2019
Q2 | $2.41M | Sell |
28,482
-23,576
| -45% | -$1.99M | 0.02% | 235 |
|
|
2019
Q1 | $4.59M | Buy |
52,058
+575
| +1% | +$50.7K | 0.03% | 127 |
|
|
2018
Q4 | $3.68M | Buy |
+51,483
| New | +$3.68M | 0.02% | 141 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1473 |
|